BPC 157 10mg+GHK-CU 50mg+TB500 10mg+KPV 10mg
Typical Dosing Protocols (Research/Compounded Use Only) – BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg + KPV 10mg Blend
Common protocol: 0.08–0.15 mL (8–15 units on U-100 insulin syringe) subcutaneously once daily. Most users start at 8–10 units daily and titrate up to 12–15 units based on tolerance and response.
Other reported ranges:
Daily for 4–8 weeks (standard cycle length for healing/skin repair).
Intensive protocols: 12–20 units daily for 3–6 weeks (e.g., post-injury or advanced skin rejuvenation).
Maintenance: 8–10 units 3–5 times per week after the loading phase.
Reconstitution example (for the combined vial: BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg + KPV 10mg): Add 2 mL bacteriostatic water (gentle swirling recommended).
Every 0.1 mL (10 units) ≈ 2.5 mg GHK-Cu + 0.5 mg BPC-157 + 0.5 mg TB-500 + 0.5 mg KPV
Common starting dose 0.08–0.1 mL (8–10 units) ≈ 2–2.5 mg GHK-Cu + 0.4–0.5 mg each of BPC-157, TB-500, and KPV.
Administration: Subcutaneous injection (abdomen or thigh). Localized injection near injury sites or target skin areas is also common. Store reconstituted vial in the refrigerator.
Dosing is highly individualized based on goals (healing, skin rejuvenation, inflammation control) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
